INTRODUCTION
============

Historically, because of visibility issues and the complicated relationship between the liver and its vasculature, hepatectomy has presented a challenge to the surgeon. Laparoscopy for liver resection was first documented in the early 1990s, proving to be as safe as conventional open hepatectomy while retaining oncologic integrity.^[@B1][@B2][@B7]^ However, laparoscopy has limitations in transection, mobilization, and the ability to control bleeding. To overcome some of these shortcomings, robot-assisted approaches have been devised and implemented that broaden visualization from 2 dimensions to 3 dimensions and increase range of motion to 360° via the EndoWrist (Intuitive Surgical Inc., Sunnyvale, California). Although minimally invasive approaches to surgery are known to decrease postoperative pain scores and length of hospitalization (LOH), with the rising costs of health care, controversy continues to surround discussions of these approaches.

The focus of this study is to evaluate the role of minimally invasive techniques in liver surgery as compared with a conventional open approach. We compared data related to operative time, perioperative complications, LOH, surgical margins, mortality rates, and cost analysis to assess differing approaches. This is the first systematic review to include analysis of the robotic approach, reflecting trends in modern surgery.

MATERIALS AND METHODS
=====================

Identification of Trials and Data Extraction
--------------------------------------------

Two independent reviewers conducted a systematic search of PubMed and Embase on articles published until August 2013. The following medical subject headings were used to locate articles: liver robotic, hepatic robotic, hepatic laparoscopic, hepatectomy laparoscopic, and hepatectomy open. The inclusion criteria for articles were as follows: (1) articles comparing conventional open liver resection with either a laparoscopic or robotic approach; (2) controlled clinical trials, multicenter studies, or randomized controlled trials; (3) studies that reported outcomes of intraoperative and postoperative outcomes, including total operative time, estimated blood loss (EBL), LOH, surgical margins, postoperative complications, and postoperative mortality rates; and (4) studies that reported a measure of variance (standard error, standard deviation, or confidence interval \[CI\]). The references of articles included in the analysis were manually searched for additional articles for inclusion. Excluded from analysis were articles on resection of colorectal cancer with synchronous liver metastasectomy and articles not published in English. In instances in which research groups reported findings using shared patient populations, the earliest publication by that research group was included for analysis. The results from the 2 independent reviews were compared for accuracy, with disagreement resolved by consensus. To achieve completeness and to assemble the most representative patient database, series with limited sample sizes were included so that their experience would find meaning in aggregate.

Statistical Analysis
--------------------

The primary outcomes of interest in this study were total operative time, EBL, LOH, surgical margins, perioperative complications, and postoperative mortality rates. A cost analysis was included as a secondary outcome of interest. For continuous outcomes, mean net changes were calculated as primary outcomes, whereas for categorical outcomes, odds ratios (ORs) were calculated to examine the treatment effect. DerSimonian and Laird random-effects models were used to pool mean net changes or ORs across the studies.^[@B8]^ The presence of heterogeneity was assessed with the Cochran Q test, and the extent of heterogeneity was quantified with the I^2^ index. To assess publication bias, funnel plots were constructed for each outcome. The Begg rank correlation test was used to examine the asymmetry of the funnel plot, and the Egger weighted linear regression test was used to examine the association between the mean effect estimate and its variance. In addition, sensitivity analyses were conducted by excluding each study in turn to evaluate its relative influence on the pooled estimates. All analyses were conducted using Stata software, version 10 (StataCorp, College Station, Texas).

RESULTS
=======

Search Results
--------------

Eight hundred seventy-three abstracts were identified, 867 of which were obtained via searches of 2 databases, with an additional 6 retrieved through manual searches of references. The final set of articles undergoing analysis was attained using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (**[Figure 1](#F1){ref-type="fig"}**).^[@B9]^ Of the 873 abstracts identified, 55 underwent full-text review and 49 articles are included in this meta-analysis, with 3 comparing laparoscopic liver resection with robotic hepatectomy^[@B10][@B11][@B12]^ and 46 comparing laparoscopic liver resection with a conventional open approach (**[Table 1](#T1){ref-type="table"}**).^[@B13][@B14][@B58]^

![Preferred Reporting Items for Systematic Reviews and Meta-Analyses flowchart showing literature search and study selection.^[@B9]^ LH = laparoscopic hepatectomy; OH = open hepatectomy; RH = robotic hepatectomy.](jls9991434360001){#F1}

###### 

Studies Selected for Meta-Analysis

  Authors                     Year   Country       Journal                                Comparison                                                                     n
  --------------------------- ------ ------------- -------------------------------------- ------------------------------------------------------------------------------ -----
  Packiam et al^[@B10]^       2012   USA           *J Gastrointest Surg*                  LH^[a](#TF1-1){ref-type="table-fn"}^ vs RH^[a](#TF1-1){ref-type="table-fn"}^   29
  Berber et al^[@B11]^        2010   USA           *HPB*                                  LH vs RH                                                                       32
  Troisi et al^[@B12]^        2013   Belgium       *Int J Med Robot*                      LH vs RH                                                                       263
  Inoue et al^[@B13]^         2013   Japan         *Am Surg*                              LH vs OH^[a](#TF1-1){ref-type="table-fn"}^                                     47
  Slakey et al^[@B14]^        2013   USA           *JSLS*                                 LH vs OH                                                                       62
  Kim et al^[@B15]^           2011   South Korea   *J Korean Surg Soc*                    LH vs OH                                                                       55
  Abu Hilal et al^[@B16]^     2008   UK            *Eur J Surg Oncol*                     LH vs OH                                                                       44
  Endo et al^[@B17]^          2009   USA           *Surg Laparosc Endosc Percutan Tech*   LH vs OH                                                                       21
  Cai et al^[@B18]^           2009   Germany       *Surg Endosc*                          LH vs OH                                                                       38
  Ito et al^[@B19]^           2009   USA           *J Gastrointest Surg*                  LH vs OH                                                                       130
  Morino et al^[@B20]^        2003   USA           *Surg Endosc*                          LH vs OH                                                                       60
  Belli et al^[@B21]^         2007   Italy         *Surg Endosc*                          LH vs OH                                                                       46
  Aldrighetti et al^[@B22]^   2008   USA           *J Gastrointest Surg*                  LH vs OH                                                                       40
  Topal et al^[@B23]^         2008   USA           *Surg Endosc*                          LH vs OH                                                                       152
  Kandil et al^[@B24]^        2012   USA           *Surgery*                              LH vs OH                                                                       36
  Cannon et al^[@B25]^        2012   USA           *Surgery*                              LH vs OH                                                                       175
  Polat^[@B26]^               2012   Turkey        *Surg Laparosc Endosc Percutan Tech*   LH vs OH                                                                       19
  Johnson et al^[@B27]^       2012   USA           *J Am Coll Surg*                       LH vs OH                                                                       212
  Bhojani et al^[@B28]^       2012   Canada        *J Am Coll Surg*                       LH vs OH                                                                       171
  Tranchart et al^[@B29]^     2010   France        *Surg Endosc*                          LH vs OH                                                                       84
  Tang et al^[@B30]^          2005   Hong Kong     *Surg Endosc*                          LH vs OH                                                                       17
  Lesurtel et al^[@B31]^      2003   France        *J Am Coll Surg*                       LH vs OH                                                                       38
  Cheung et al^[@B32]^        2013   Hong Kong     *Ann Surg*                             LH vs OH                                                                       60
  Kobayashi et al^[@B33]^     2013   Japan         *Surg Endosc*                          LH vs OH                                                                       83
  Slim et al^[@B34]^          2012   Italy         *Langenbecks Arch Surg*                LH vs OH                                                                       92
  Hu et al^[@B35]^            2012   China         *Surg Laparosc Endosc Percutan Tech*   LH vs OH                                                                       26
  Hu et al^[@B36]^            2011   China         *World J Gastroenterol*                LH vs OH                                                                       60
  Gustafson et al^[@B37]^     2012   USA           *Surg Endosc*                          LH vs OH                                                                       76
  Nguyen et al^[@B38]^        2011   USA           *Arch Surg*                            LH vs OH                                                                       86
  Tu et al^[@B39]^            2011   China         *World J Gastroenterol*                LH vs OH                                                                       31
  Vanounou et al^[@B40]^      2010   Canada        *Ann Surg Oncol*                       LH vs OH                                                                       73
  Castaing et al^[@B41]^      2009   France        *Ann Surg*                             LH vs OH                                                                       120
  Carswell et al^[@B42]^      2009   UK            *BMC Surg*                             LH vs OH                                                                       20
  Dagher et al^[@B43]^        2009   France        *Am J Surg*                            LH vs OH                                                                       72
  Rowe et al^[@B44]^          2009   Canada        *Surg Endosc*                          LH vs OH                                                                       30
  Sarpel et al^[@B45]^        2009   USA           *Ann Surg Oncol*                       LH vs OH                                                                       76
  Tsinberg et al^[@B46]^      2009   USA           *Surg Endosc*                          LH vs OH                                                                       74
  Cai et al^[@B47]^           2008   China         *Surg Endosc*                          LH vs OH                                                                       62
  Lee et al^[@B48]^           2007   Hong Kong     *Hong Kong Med J*                      LH vs OH                                                                       50
  Mala et al^[@B49]^          2002   Norway        *Surg Endosc*                          LH vs OH                                                                       27
  Rau et al^[@B50]^           1998   Germany       *Hepatogastroenterology*               LH vs OH                                                                       34
  Shimada et al^[@B51]^       2001   Japan         *Surg Endosc*                          LH vs OH                                                                       55
  Farges et al^[@B52]^        2002   France        *J Hepatobiliary Pancreat Surg*        LH vs OH                                                                       42
  Laurent et al^[@B53]^       2003   France        *Arch Surg*                            LH vs OH                                                                       27
  Kaneko et al^[@B54]^        2005   Japan         *Am J Surg*                            LH vs OH                                                                       58
  Polignano et al^[@B55]^     2008   UK            *Surg Endosc*                          LH vs OH                                                                       50
  Lai et al^[@B56]^           2009   China         *Arch Surg*                            LH vs OH                                                                       58
  Truant et al^[@B57]^        2011   France        *Surg Endosc*                          LH vs OH                                                                       89
  Koffron et al^[@B58]^       2007   USA           *Ann Surg*                             LH vs OH                                                                       400

LH = laparoscopic hepatectomy; OH = open hepatectomy; RH = robotic hepatectomy.

Description of Included Trials and Demographic Data
---------------------------------------------------

The 49 articles analyzed represent a total of 3702 patients, with sample sizes ranging from 17 to 400 patients. The distribution of the patients was as follows: 60 in the robotic group, 1901 in the laparoscopic group, and 1741 in the open group. Baseline patient demographic data, including sex, age, and body mass index, were well matched among groups (**[Table 2](#T2){ref-type="table"}**) Distribution of resection type by the 40 articles mentioning this characteristic is listed in **[Table 3](#T3){ref-type="table"}**.^[@B11][@B12][@B17],[@B19][@B20][@B25],[@B27][@B28][@B32],[@B34],[@B35],[@B37][@B38][@B39],[@B41][@B42][@B44],[@B46][@B47][@B48],[@B51][@B52][@B58]^

###### 

Demographic Characteristics

  Characteristic                                         Total (%)     LH^[a](#TF2-1){ref-type="table-fn"}^   OH^[a](#TF2-1){ref-type="table-fn"}^   RH^[a](#TF2-1){ref-type="table-fn"}^
  ------------------------------------------------------ ------------- -------------------------------------- -------------------------------------- --------------------------------------
  Sex                                                                                                                                                
      Male                                               1535 (48.7)   712                                    786                                    37
      Female                                             1329 (42.1)   705                                    601                                    23
  Age, y                                                 58.95         58.79                                  58.87                                  62.73
  BMI^[a](#TF2-1){ref-type="table-fn"}^                  26.67         26.46                                  26.31                                  31.00
  Lesions                                                                                                                                            
      Mean number                                        3.26          4.35                                   2.72                                   1.49
      Mean size, cm                                      5.11          4.86                                   4.06                                   27.50
  Surgical indication                                                                                                                                
      CRC^[a](#TF2-1){ref-type="table-fn"}^ metastases   836           396                                    412                                    28
      Adenoma                                            117           110                                    7                                      0
      FNH^[a](#TF2-1){ref-type="table-fn"}^              127           109                                    18                                     0
      Hemangioma                                         114           85                                     23                                     6
      HCC^[a](#TF2-1){ref-type="table-fn"}^              951           436                                    509                                    6
      Hydatid cyst                                       108           86                                     18                                     4
      Living donor                                       52            32                                     20                                     0
      Cholangiocarcinoma                                 15            8                                      6                                      1

BMI = body mass index; CRC = colorectal cancer; FNH = focal nodular hyperplasia; HCC = hepatocellular carcinoma; LH = laparoscopic hepatectomy; OH = open hepatectomy; RH = robotic hepatectomy.

###### 

Resection Type

  Resection Type               LH^[a](#TF3-1){ref-type="table-fn"}^   OH^[a](#TF3-1){ref-type="table-fn"}^   RH^[a](#TF3-1){ref-type="table-fn"}^
  ---------------------------- -------------------------------------- -------------------------------------- --------------------------------------
  Monosegmentectomy            304                                    250                                    7
  Subsegmentectomy/wedge       270                                    249                                    15
  Bisegmentectomy              173                                    141                                    8
  Left lateral sectionectomy   323                                    231                                    2
  Right trisegmentectomy       7                                      6                                      0
  Mixed segments               26                                     0                                      8
  Right hepatectomy            173                                    169                                    0
  Left hepatectomy             113                                    72                                     0
  R extended hepatectomy       12                                     22                                     0
  Major hepatectomy            110                                    119                                    0
  Nonanatomical/atypical       105                                    88                                     0
  P-S segment                  110                                    37                                     22

LH = laparoscopic hepatectomy; OH = open hepatectomy; RH = robotic hepatectomy.

Perioperative Outcomes
----------------------

Forty-six publications reported total operative length, with similar results among groups^[@B10][@B11][@B13],[@B15][@B16][@B24],[@B26][@B27][@B36],[@B38][@B39][@B58]^ (**[Figure 2](#F2){ref-type="fig"}a**). The mean total operative time was 203.6 minutes, 203.9 minutes, and 234.8 minutes for the laparoscopic, open, and robotic groups, respectively.

![Forest plots and pooled analyses of mean difference in length of hospitalization (a), operative time (b), estimated blood loss (c), and odds ratio of postoperative complications (d). The mean difference is reported for each study (black boxes). LH = laparoscopic hepatectomy; OH = open hepatectomy.](jls9991434360002){#F2}

Regarding EBL, 44 studies reported this variable.^[@B10][@B11][@B14],[@B16][@B17][@B25],[@B27][@B28][@B39],[@B43],[@B44],[@B46][@B47][@B58]^ There was no difference between minimally invasive approaches, and there was a statistically significant increase in blood loss in laparotomy cases as compared with laparoscopy cases, with a pooled net mean change of 152.0 mL (95% CI, 103.3--200.8 mL) (**[Figure 2](#F2){ref-type="fig"}b**).

The total number of conversions in the laparoscopic group was 106, which represents a 5.68% conversion rate to open surgery. In the robotic group, 9 cases required conversion to open surgery, representing a 15% conversion rate.

Twenty-nine studies included results of pathologic resection margin status in their analyses.^[@B13][@B14][@B16],[@B19][@B20][@B21],[@B23][@B24][@B25],[@B28],[@B29],[@B31][@B32][@B33],[@B38],[@B41][@B42][@B43],[@B45][@B46][@B49],[@B51],[@B53],[@B56],[@B57]^ Laparoscopy showed a significantly higher rate of negative surgical margins (pooled OR 1.06) as compared with laparotomy (pooled OR 1.01).

Postoperative Considerations
----------------------------

Forty-four studies reported LOH.^[@B10],[@B12],[@B13],[@B15][@B16][@B32],[@B34][@B35][@B40],[@B42][@B43][@B44],[@B46][@B47][@B58]^ As compared with patients undergoing the laparoscopic approach, those undergoing a conventional open approach had a significantly longer LOH (pooled mean difference, 2.22 days; 95% CI, 1.78--2.66 days) (**[Figure 2](#F2){ref-type="fig"}c**).

Postoperative morbidity, including wound infection, biliary leakage, pleural effusion, bleeding, fluid collection, incisional hernia formation, renal failure, and ascites or cirrhotic decompensation, was reported by 47 articles.^[@B10][@B11][@B32],[@B34][@B35][@B41],[@B43][@B44][@B58]^ For total postoperative complications, minimally invasive approaches showed similar results with a rate significantly lower than that of the open group (OR, 0.49; 95% CI, 0.42--0.57) (**[Figure 2](#F2){ref-type="fig"}d**). Specifically, minimally invasive approaches had lower rates of wound infections (OR, 0.39; 95% CI, 0.22--0.68), incisional hernias (OR, 0.20; 95% CI, 0.06--0.67), and ascites and cirrhotic decompensation events (OR, 0.50; 95% CI, 0.29--0.87) than the open group.

Forty studies reported data on postoperative mortality rates.^[@B10][@B11][@B20],[@B22][@B23][@B37],[@B39][@B40][@B43],[@B45][@B46][@B49],[@B53],[@B54],[@B56],[@B57]^ There were no statistically significant differences between laparotomy and minimally invasive approaches for rates of both in-hospital mortality (OR, 1.01; 95% CI, 0.67--1.54) and postoperative mortality within 30 days of discharge (OR, 0.88; 95% CI, 0.41--1.88).

Cost Analysis
-------------

Eight studies included cost analyses and discussion on this outcome.^[@B10],[@B28],[@B38],[@B40],[@B44],[@B46],[@B55],[@B58]^ Of these, one was excluded because it was out of scope.^[@B58]^ Four studies reported cost differences between minimally invasive approaches and conventional approaches, with three comparing laparotomy with laparoscopy and one comparing a robotic approach with an open approach.^[@B10],[@B28],[@B46],[@B55]^ These studies showed a nonsignificant trend of higher total operative costs of \$334.10 (95% CI, --\$753.50--\$1421.60) for minimally invasive approaches. Four studies reported total hospital cost differences, with all comparing laparotomy with laparoscopy.^[@B28],[@B40],[@B46],[@B55]^ These researchers found a trend of higher total hospital costs in patients undergoing the conventional open approach of \$3223 (95% CI, --\$474--\$692). Of note, one additional article normalized cost values for both total operative costs and total hospital costs and was subsequently not included in the statistical analysis.^[@B38]^

DISCUSSION
==========

This meta-analysis of 3702 patients over a 14-year period yielded 49 pertinent studies showing minimally invasive approaches for hepatectomy to be as safe and efficacious as conventional laparotomy, with similar total operative times. Minimally invasive approaches afford shorter LOH, decreased EBL, and decreased postoperative morbidity. Specifically, these approaches resulted in fewer incisional hernias, wound infections, and ascites or cirrhotic decompensation events and retained oncologic integrity. All approaches to liver resection resulted in similar mortality rates. In terms of cost, minimally invasive approaches required nearly the same amount of money in the operating room as the conventional approach but saved money over the entire LOH.

Favorable operative outcomes, such as decreased EBL and lower rates of postoperative morbidity, lend credence to increased implementation of minimally invasive approaches. Bile leaks and massive hemorrhages are two important perioperative considerations in hepatic surgery owing to the unique anatomic structure of the liver, with minimally invasive approaches showing decreased intraoperative blood loss and equitable postoperative bile leak rates. The observed lower EBL is likely multifactorial, owing to both hepatic vein tamponade from pneumoperitoneum and improved dissection via field magnification. Furthermore, higher EBL and consequent blood transfusions are associated with increased postoperative morbidity, helping explain the lower rates of postoperative morbidity observed in this study.^[@B59]^

Long-term mortality rates were reported for 22 of the included study samples.^[@B11],[@B15],[@B17],[@B19],[@B24],[@B25],[@B29],[@B32],[@B33],[@B35],[@B36],[@B38],[@B41],[@B45],[@B47],[@B48],[@B51],[@B53],[@B54],[@B56],[@B57]^ When immediate postoperative deaths were excluded, nonsignificant differences were found between laparoscopic hepatectomy and open hepatectomy for overall survival and for disease-free survival by all research groups except one. Kandil et al^[@B24]^ found no difference in overall survival (*P* = .818) but found a significant difference in disease-free survival, with 100% 3-year survival in laparoscopic hepatectomy patients versus 71.4% survival in open hepatectomy patients (*P* = .03). Of note, the operative indication for this research group was neuroendocrine metastasis, whereas the indications for the remaining groups were primarily hepatocellular carcinoma or colorectal cancer metastases (**[Table 2](#T2){ref-type="table"}**). Perhaps a survival advantage exists in this population of patients; however, further studies are needed to establish the potential validity of this relationship.

A focus of debate regarding implementation of minimally invasive surgery centers on cost. In comparing total operative costs and total hospital costs among groups, studies found that although operative costs were higher for laparoscopic groups, their hospitalization costs were lower because of shorter LOH, which is intimately tied to postoperative morbidity, as well as decreased intensive care unit admission rates.^[@B38],[@B40],[@B60]^ Only 1 article assessed comparative costs between robotic and conventional open approaches, finding increased operating room costs with the robotic approach.^[@B10]^ However, without discussion of total hospital costs, no conclusions can be drawn from that study regarding the potential financial tradeoff gained by implementing robotic intervention. Further studies including the economic impact of minimally invasive surgery are needed to advance this discussion.

Minimally invasive approaches to surgery afford the surgeon increased visibility and the patient decreased LOH, improved cosmesis, and decreased postoperative pain. Colorectal metastases are a leading indication for hepatectomy, for which a majority of patients need repeat hepatectomy. Minimally invasive approaches not only better facilitate reoperations in this patient population but also allow for simultaneous operations in colorectal cancer patients with synchronous hepatic metastases.^[@B61][@B62][@B64]^

Although this study is comprehensive and is the most current evaluation of approaches to liver resection, there are several limitations and shortcomings to our study. First, the included studies are nonrandomized, retrospective studies, making them of moderate quality with increased selection bias. Also contributing to selection bias was patient selection by the surgeon, wherein healthier patients more fit for surgery were more likely to undergo minimally invasive options, leading to more favorable postoperative outcomes. Furthermore, patients selected for laparoscopic surgery may have had more easily resectable tumors, possibly contributing to their relative increase in negative margins. Intimately linked to minimally invasive surgical outcomes is both the surgeon\'s experience with the procedure and the volume of cases to which each care center is accustomed, neither of which was included in these studies, thereby prohibiting subanalysis. These studies exhibited moderate heterogeneity, with varying surgical techniques and differing outcome measures. Specifically, significant heterogeneity in reporting of resection outcomes, positive and negative versus R0--R1, prevents subanalysis of this outcome.

Although 873 citations were initially identified, an overwhelming majority of these were out of scope, focusing on tangential topics relating to liver donations, radiofrequency ablation, and tumor staging. Moreover, although these articles may have marginally touched on some of our primary outcomes, they neglected to contain data pertinent to this study. Furthermore, patient overlap by research groups led to the exclusion of 5 articles from analysis, totaling 488 patient experiences that are not represented.

The only statistically significant difference noted between minimally invasive approaches was a roughly 10% lower conversion rate to open surgery in the laparoscopic group as compared with the robotic group. With only 3 comparative studies including a robotic group, the ability to accurately ascertain any relationship to the robotic group is limited by its underpowering and the subsequent inability to perform subgroup analysis. Further comparative studies that include robotic approaches are needed. At present, the limited volume is likely because of the financial investment and operative training required to implement robots into common surgical practice.

CONCLUSION
==========

To our knowledge, this review represents the largest, most current analysis of outcomes related to minimally invasive approaches to hepatectomy, with minimally invasive approaches showing improved postoperative morbidity, retained oncologic integrity, and potentially decreased economic burden to the health care system. Furthermore, future research comparing the robotic approach with the laparoscopic approach, as well as assessing the cost associated with each approach, is warranted.

[^1]: All financial and material support for this work was provided by Tulane University and Tulane University Hospital.
